Adding dexmedetomidine to spinal bupivacaine for pain relief during knee surgery
Official title: The Analgesic Effect of Intrathecal Dexmedetomidine With Bupivacaine, in Patients Undergoing Knee Orthopedic Surgery: A Randomized Double-Blinded Dose-Finding Trial
Run by Cairo University · NCT07522736 · Data updated 2026-11-12
This trial tests whether small intrathecal doses of dexmedetomidine added to spinal bupivacaine can prolong pain relief after knee surgery in adult men.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo) |
| Status | Recruiting |
| Started | March 1, 2025 |
| Main results expected | August 30, 2026 |
| Study ends | August 30, 2026 |
| Registry record updated | April 13, 2026 |
| Trial ID | NCT07522736 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are male adults aged 18–65 with ASA I–II scheduled for knee orthopedic surgery who have no contraindications to regional anesthesia.
✕Probably not a fit
Patients who are female, outside the 18–65 age range, have contraindications to regional anesthesia, a history of hypersensitivity to the drugs, psychiatric disorders, or recent opioid/CNS depressant use are unlikely to qualify or benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial compares three intrathecal doses of dexmedetomidine (4, 8, and 12 μg) given with hyperbaric bupivacaine for patients undergoing knee orthopedic surgery. The primary outcome is duration of analgesia and the secondary outcome is the profile of adverse effects. Male adults aged 18–65 with ASA physical status I–II are eligible and receive a single spinal anesthetic with the assigned adjunct dose. The study is conducted at a single center (Cairo University) and monitors postoperative pain duration and safety measures without increasing the local anesthetic dose.
Why it matters
Potential benefit: If successful, adding intrathecal dexmedetomidine could provide longer-lasting spinal anesthesia and reduce the need for postoperative opioids.
How similar studies have gone: Previous clinical reports have shown that dexmedetomidine as an intrathecal adjunct can enhance and prolong analgesia, though optimal dosing strategies remain under study.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age from 18 to 65 years. * American Society of Anesthesiologists (ASA) physical status I-II. * Male patients scheduled for knee orthopedic surgery. Exclusion Criteria: * Patients with psychiatric disorders. * History of drug addiction. * Contraindication for regional anesthesia. * History of hypersensitivity to the study drugs. * Previous administration of opioids and/or other central nervous system depressants during current hospital admission.
Where it's running
-
Cairo University
Cairo, Egypt Recruiting
Study contacts
- Study coordinator: Ahmed A Ismail, MSc
- Email: ahmed.ali39348@postgrad.kasralainy.edu.eg
- Phone: 00201115746779
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intraparotid injection of bupivacaine with dexamethasone after partial parotidectomy
This early-phase study tests whether a single intraparotid injection of bupivacaine with dexamethasone is safe and tolerable after partial parotidectomy for a benign tumor.
-
Intrathecal Morphine or Dexmedetomidine for Pain After Spine Fixation
This study tests whether delivering pain medicine into the spinal fluid with morphine or dexmedetomidine can better relieve pain after lumbar spine fixation surgery compared with placebo.
-
Dexamethasone and Bupivacaine in a Shoulder Nerve Block: How It Affects Blood Levels
This study tests whether giving dexamethasone with a shoulder block affects the blood level of bupivacaine after a single injection.
-
Intrathecal dexmedetomidine plus fentanyl with bupivacaine for spinal anesthesia during above-knee amputation
This trial will test whether adding intrathecal dexmedetomidine to fentanyl and bupivacaine gives better and longer pain relief after above-knee amputation for adults with lower-limb sarcoma.
-
Transversalis fascia plane block versus intrathecal dexmedetomidine for pain after cesarean section
This will try whether an ultrasound-guided transversalis fascia plane (TFP) nerve block or injecting dexmedetomidine into the spinal fluid gives better pain relief for women having a cesarean under spinal anesthesia.
-
Comparing dexmedetomidine and bupivacaine for pain management after brain surgery
This study is testing if adding dexmedetomidine to bupivacaine can help reduce pain better after brain surgery compared to using bupivacaine alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.